Smart Magnetic Drug Delivery Systems for the Treatment of Cancer

• Published in: Nanomaterials (Basel, Switzerland) Vol. 13; no. 5; p. 876
• Main Authors: Spoială, Angela, Ilie, Cornelia-Ioana, Motelica, Ludmila, Ficai, Denisa, Semenescu, Augustin, Oprea, Ovidiu-Cristian, Ficai, Anton
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 26.02.2023; MDPI
• Subjects: active targeting; Analysis; Biocompatibility; Blood; Cancer; Cancer therapies; Care and treatment; Cell division; Chemotherapy; Clinical trials; Cytotoxicity; Diagnosis; Disadvantages; Disease; Drug delivery; Drug delivery systems; Drugs; Health care; Immunotherapy; linkers; Magnetic fields; magnetic nanoparticles; Medical research; Methods; Morbidity; Multidrug resistance; Mutation; Nanoparticles; Nanotechnology; passive targeting; Permeability; Pharmaceutical industry; Polyethylene glycol; Quantum dots; Radiation; Radiation therapy; Review; targeting nanoparticles; Toxicity; Vehicles; Romania; linkers; magnetic nanoparticles; passive targeting; active targeting; targeting nanoparticles
• ISSN: 2079-4991; 2079-4991
• DOI: 10.3390/nano13050876

Cancer remains the most devastating disease, being one of the main factors of death and morbidity worldwide since ancient times. Although early diagnosis and treatment represent the correct approach in the fight against cancer, traditional therapies, such as chemotherapy, radiotherapy, targeted therapy, and immunotherapy, have some limitations (lack of specificity, cytotoxicity, and multidrug resistance). These limitations represent a continuous challenge for determining optimal therapies for the diagnosis and treatment of cancer. Cancer diagnosis and treatment have seen significant achievements with the advent of nanotechnology and a wide range of nanoparticles. Due to their special advantages, such as low toxicity, high stability, good permeability, biocompatibility, improved retention effect, and precise targeting, nanoparticles with sizes ranging from 1 nm to 100 nm have been successfully used in cancer diagnosis and treatment by solving the limitations of conventional cancer treatment, but also overcoming multidrug resistance. Additionally, choosing the best cancer diagnosis, treatment, and management is extremely important. The use of nanotechnology and magnetic nanoparticles (MNPs) represents an effective alternative in the simultaneous diagnosis and treatment of cancer using nano-theranostic particles that facilitate early-stage detection and selective destruction of cancer cells. The specific properties, such as the control of the dimensions and the specific surface through the judicious choice of synthesis methods, and the possibility of targeting the target organ by applying an internal magnetic field, make these nanoparticles effective alternatives for the diagnosis and treatment of cancer. This review discusses the use of MNPs in cancer diagnosis and treatment and provides future perspectives in the field.